Bide Pharmatech Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 9.08% vs 13.30% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 52.44% vs 17.62% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "323.30",
          "val2": "296.40",
          "chgp": "9.08%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "64.20",
          "val2": "49.20",
          "chgp": "30.49%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.10",
          "val2": "2.20",
          "chgp": "-50.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.60",
          "val2": "1.70",
          "chgp": "-64.71%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "46.80",
          "val2": "30.70",
          "chgp": "52.44%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "198.50%",
          "val2": "132.30%",
          "chgp": "6.62%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 1.07% vs 30.94% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 8.30% vs -25.75% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,098.30",
          "val2": "1,086.70",
          "chgp": "1.07%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "154.20",
          "val2": "139.70",
          "chgp": "10.38%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "5.30",
          "val2": "4.40",
          "chgp": "20.45%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "3.50",
          "val2": "-13.00",
          "chgp": "126.92%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "117.40",
          "val2": "108.40",
          "chgp": "8.30%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "100.70%",
          "val2": "90.70%",
          "chgp": "1.00%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY

Mar'26

Mar'25

Change(%)

Net Sales

323.30

296.40

9.08%

Operating Profit (PBDIT) excl Other Income

64.20

49.20

30.49%

Interest

1.10

2.20

-50.00%

Exceptional Items

0.60

1.70

-64.71%

Consolidate Net Profit

46.80

30.70

52.44%

Operating Profit Margin (Excl OI)

198.50%

132.30%

6.62%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Mar 2026 is 9.08% vs 13.30% in Mar 2025

Consolidated Net Profit

YoY Growth in quarter ended Mar 2026 is 52.44% vs 17.62% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

1,098.30

1,086.70

1.07%

Operating Profit (PBDIT) excl Other Income

154.20

139.70

10.38%

Interest

5.30

4.40

20.45%

Exceptional Items

3.50

-13.00

126.92%

Consolidate Net Profit

117.40

108.40

8.30%

Operating Profit Margin (Excl OI)

100.70%

90.70%

1.00%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 1.07% vs 30.94% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 8.30% vs -25.75% in Dec 2023

All Annual Results